Intelligent Cryogenic Tissue Remodeling System
Legal Citation
Summary of the Inventive Concept
An advanced cryogenic system that utilizes real-time tissue impedance measurements, nanofluidics, and micro-sensors to dynamically adjust the cooling zone, enabling precise and minimally invasive tissue remodeling for a wide range of cosmetic and therapeutic applications.
Background and Problem Solved
The original patent, 'Cryogenic needle with freeze zone regulation,' provided a significant advancement in cryogenic tissue remodeling. However, it had limitations in terms of precision, control, and adaptability to varying tissue types and conditions. The new inventive concept addresses these limitations by introducing real-time tissue impedance measurements, advanced fluid delivery systems, and integrated micro-sensors, enabling a more targeted and effective treatment approach.
Detailed Description of the Inventive Concept
The Intelligent Cryogenic Tissue Remodeling System consists of a cryogenic needle with a built-in freeze zone regulation module, which dynamically adjusts the cooling zone based on real-time tissue impedance measurements. The system also incorporates a nanofluidics and microfluidics-based cryogenic fluid delivery module, allowing for highly localized and controlled cooling. Additionally, the system features a micro-sensor array that detects and responds to changes in tissue temperature, impedance, and hydration levels, providing real-time feedback for optimizing treatment parameters. This integrated system enables the creation of three-dimensional tissue matrices that reinforce target tissue structure, improve skin elasticity, and reduce wrinkles, as well as the selective targeting and destruction of diseased tissue cells while preserving healthy surrounding tissue.
Novelty and Inventive Step
The new claims introduce several novel and non-obvious features, including the use of real-time tissue impedance measurements, nanofluidics and microfluidics-based cryogenic fluid delivery, and integrated micro-sensors. These advancements enable a level of precision, control, and adaptability that was not possible with the original patent, and thus represent a significant inventive step forward.
Alternative Embodiments and Variations
Alternative embodiments of the Intelligent Cryogenic Tissue Remodeling System could include the use of different types of sensors, such as optical or acoustic sensors, or the integration of additional treatment modalities, such as ultrasound or electromagnetic energy. Variations could also include the development of specialized cryogenic needles for specific tissue types or applications, such as dermatological or oncological treatments.
Potential Commercial Applications and Market
The Intelligent Cryogenic Tissue Remodeling System has significant commercial potential in the cosmetic and therapeutic industries, with potential applications in skin rejuvenation, wrinkle reduction, and the treatment of skin lesions and diseases. The system's ability to provide precise and minimally invasive treatments could also make it an attractive option for patients seeking to avoid more invasive surgical procedures.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B18/02 |
| A | A61 | A61B2017/00473 |
| A | A61 | A61B2018/00029 |
| A | A61 | A61B2018/00041 |
| A | A61 | A61B2018/00648 |
| A | A61 | A61B2018/00714 |
| A | A61 | A61B2018/00738 |
| A | A61 | A61B2018/00744 |
| A | A61 | A61B2018/00779 |
| A | A61 | A61B2018/00791 |
| A | A61 | A61B2018/00898 |
| A | A61 | A61B2018/00994 |
| A | A61 | A61B2018/0262 |
| A | A61 | A61B2018/0293 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device technologies for cryogenic tissue treatment, specifically focusing on dermatological and cosmetic interventions involving precision cooling systems with temperature and fluid regulation
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with expertise in cryogenic technologies, microfluidics, sensor integration, and tissue remodeling techniques, possessing advanced knowledge of thermal control systems and minimally invasive medical interventions
Obviousness Rationale
A PHOSITA would recognize that the PTD's disclosed variations represent predictable technological extensions of the source patent's core cryogenic needle technology. The additional elements like tissue impedance measurement, nanofluidic control, and micro-sensor integration are logical incremental improvements that address known limitations in precise tissue cooling. These variations demonstrate standard engineering problem-solving approaches within the established technological framework of cryogenic medical devices.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,239 |
|---|---|
| Title | Cryogenic needle with freeze zone regulation |
| Assignee(s) | Pacira CryoTech, Inc. |